CymitQuimica logo

CAS 61199-83-5

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits concernés.
  • L-Iduronic acid sodium salt

    CAS :
    L-Iduronic acid sodium salt is a monosaccharide that is an important component of glycosaminoglycans (GAGs) such as heparin, heparan sulfate, and dermatan
    Formule :C6H9NaO7
    Couleur et forme :Solid
    Masse moléculaire :216.12

    Ref: TM-T36111

    1mg
    255,00€
    5mg
    1.119,00€
    10mg
    1.993,00€
  • L-Iduronic Acid Sodium Salt

    CAS :

    Stability Hygroscopic
    Applications A constituent of certain mucopolysaccharides.
    References Hoffman, P., et al.: Science, 124, 1252 (1956), Meyer, K: Biochim et Biophys. Acta, 21, 506 (1956), Cifonelli, J.A., et al.: Federation Proc., 16, 165 (1957), Cifonelli, J.A., et al.: J. Biol. Chem., 233, 541 (1958)

    Formule :C6H9NaO7
    Couleur et forme :Light Orange Colour To Dark Brown
    Masse moléculaire :216.12

    Ref: TR-I252000

    5mg
    321,00€
    50mg
    2.082,00€
  • L-Iduronic Acid-13C3 Sodium Salt

    Produit contrôlé
    CAS :

    Applications A labelled constituent of certain mucopolysaccharides.
    References Hoffman, P., et al.: Science, 124, 1252 (1956), Meyer, K: Biochim et Biophys. Acta, 21, 506 (1956), Cifonelli, J.A., et al.: Federation Proc., 16, 165 (1957), Cifonelli, J.A., et al.: J. Biol. Chem., 233, 541 (1958)

    Formule :C3C3H9NaO7
    Couleur et forme :Neat
    Masse moléculaire :219.099

    Ref: TR-I252002

    5mg
    10.037,00€
  • L-Iduronic acid sodium salt

    CAS :

    L-iduronic acid (IdoA) (Collins, 2006) is the major uronic acid component of the glycosaminoglycans dermatan sulfate, chondroitin sulfate and heparin. Iduronic acid is also present in heparan sulfate, although in a minor amount relative to glucuronic acid. Glycosaminoglycans represent a physiologically important group of molecules involved in a variety of biological functions, such as, cell proliferation, cell-to-cell communication, wound healing, coagulation, morphogenesis, and pathogenesis. Glycosaminoglycans present an intriguing target for the design of new approaches for diagnostic and therapeutic agents against various infectious diseases (Kamhi, 2013).

    Formule :C6H9NaO7
    Degré de pureté :Min. 95%
    Couleur et forme :Slightly Yellow Powder
    Masse moléculaire :216.12 g/mol